Possible virulence factors of Staphylococcus aureus in a mouse septic model

FEMS Immunology and Medical Microbiology

Volumn 23, Issue 2, 1999, Pages 135-146

  Tao, M ^a   Yamashita, H ^a   Watanabe, K ^a   Nagatake, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Animal model; Gram positive sepsis; Staphylococcus aureus

Indexed keywords

BACTERIAL ENZYME; BACTERIAL TOXIN; CELL MEMBRANE PROTEIN; CYTOTOXIC AGENT; FORMALDEHYDE; HEMOLYSIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; VIRULENCE FACTOR;

ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEAT TREATMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LETHALITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; SUPERNATANT; TOXIC SHOCK SYNDROME; VEIN; VERO CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD BACTERICIDAL ACTIVITY; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; ENZYMES; EXOTOXINS; FEMALE; FORMALDEHYDE; HEAT; HEMOLYSIN PROTEINS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; NEUTROPHILS; PHAGOCYTOSIS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VERO CELLS; VIRULENCE;

EID: 0033007065     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(98)00141-2     Document Type: Article

References (41)

1. Rogolsky, M. (1979) Nonenteric toxins of Staphylococcus aureus. Microbiol. Rev. 43, 320-360.
2. Bergdoll, M.S. and Schlievert, P.M. (1984) Toxic shock syndrome toxin. Lancet ii, 69.
3. Melish, M.E., Glasgow, L.A. and Turner, M.D. (1972) The Staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J. Infect. Dis. 125, 129-140.
4. Kingdom, J.C., Joyce, S.M., Bradley, W.J., Falkiner, F.R. and Keane, C.T. (1983) Staphylococcal nasal carriage in medical students with varying clinical exposure. J. Hosp. Infect. 4, 75-79.
5. Cookson, B., Peters, B., Webster, M., Phillips, I., Rahman, M. and Noble, W. (1989) Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J. Clin. Med. Microbiol. 27, 1471-1476.
6. Luzar, M.A., Coles, G.A., Faller, B., Slingeneyer, A., Dah, G.D., Briat, C., Wone, C., Knefati, Y. and Kessler, M. (1990) Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. New Engl. J. Med. 322, 505-509.
7. Muder, R.R., Brennen, C., Wagener, M.M., Vickers, R.M., Rihs, J.D., Hancock, G.A., Yee, Y.C., Miller, J.M. and Yu, V.L. (1991) Methicillin-resistant Staphylococcal colonization and infection in a long-term care facility. Ann. Intern. Med. 114, 107-112.
8. Bradley, S.F., Terpenning, M.S., Ramsey, M.A., Zarins, L.T., Jorgensen, K.A., Sottile, W.S., Schaberg, D.R. and Kauffman, C.A. (1991) Methicillin-resistant Staphylococcal aureus: Colonization and infection in a long-term care facility. Ann. Intern. Med. 115, 417-422.
9. Romero-Vivas, J., Rubio, M., Fernandez, C. and Picazo, J.J. (1995) Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 21, 1417-1423.
10. Mulligan, M.E., Murray-Leisure, K.A., Ribner, B., Standiford, H.C., John, J.F., Korvick, J.A., Kauffman, C.A. and Yu, V. (1993) Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am. J. Med. 94, 313-328.
11. Kieft, H., Hoepelman, A.I.M., Zhou, W., Rozenberg-Arska, M., Struyvenberg, A. and Verhoef, J. (1993) The sepsis syndrome in a Dutch University Hospital. Arch. Intern. Med. 153, 2241-2247.
12. Bone, R.C. (1994) Gram-positive organisms and sepsis. Arch. Intern. Med. 154, 26-34.
13. Freudenberg, M.A. and Galanos, C. (1991) Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59, 2110-2115.
14. De Kimpe, S.J., Kengatharan, M., Thiemermann, C. and Vane, J.R. (1995) The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA. 92, 10359-10363.
15. Lee, J.C., Betley, M.J., Hopkins, C.A., Perez, N.E. and Pier, G.B. (1987) Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsular size. J. Infect. Dis. 156, 741-750.
16. Reed, L.J. and Muench, H. (1937) A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27, 493-497.
17. Cutler, R.R. (1978) Relationship between antibiotic resistance, the production of 'virulence factors', and virulence for experimental animals in Staphylococcus aureus. J. Med. Microbiol. 12, 55-62.
18. Abramson, C. and Friedman, A. (1967) Enzymatic activity of primary isolates of Staphylococci in relation to antibiotic resistance and phage type. J. Infect. Dis. 117, 242.
19. Bone, R.C. (1993) How gram-positive organisms cause sepsis. J. Crit. Care 8, 51-59.
20. Peacock, J.E., Jr., Moorman, D.R., Wenzel, R.P. and Mandell, G.L. (1981) Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J. Infect. Dis. 144, 575-582.
21. Haley, R.W., Hightower, A.W., Khabbaz, R.F., Thornsberry, C., Martone, W.J. Allen, J.R. and Hughes, J.M. (1982) The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospital. Ann. Intern. Med. 97, 297-308.
22. Banerjee, S.N., Emori, T.G., Culver, D.H., Gaynes, R.P., Jarvis, W.R., Horan, T., Edwards, J.R., Tolson, J., Henderson, T., Martone, W.J. and the National Nosocomial Infections Surveillance System (1991) Secular trends in nosocomial primary bloodstream infections in the United states, 1980-1989. Am. J. Med. 91 (Suppl. 3B), 86S-89S.
23. Schaberg, D.R., Culver, D.H. and Gaynes, R.P. (1991) Major trends in the microbial etiology of nosocomial infections. Am. J. Med. 91 (Suppl. 3B), 72S-75S.
24. Heumann, D., Barras, C., Severin, A., Glauser, M.P. and Tomasz, A. (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62, 2715-2721.
25. Timmerman, C.P., Mattsson, E., Martinez-Martinez, L., De Graaf, L., Van Strijp, J.A.G., Verbrugh, H.A., Verhoef, J. and Fleer, A. (1993) Induction of release of tumor necrosis factor from human monocytes by Staphylococci and Staphylococcal peptidoglycans. Infect. Immun. 61, 4167-4172.
26. Lee, V.T.P., Chang, A.H. and Chow, A.W. (1992) Detection of Staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS associated Staphylococcus aureus isolates. J. Infect. Dis. 166, 911-915.
27. Parsonnet, J. (1989) Mediators in the pathogenesis of toxic shock syndrome: overview. Rev. Infect. Dis. 11 (Suppl. 1), S263-S269.
28. Schlievert, P.M. (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1, 1149-1150.
29. Bhakdi, S., Klonisch, T., Nuber, P. and Fischer, W. (1991) Stimulation of monokine production by lipoteichoic by lipoteichoic acids. Infect. Immun. 59, 4614-4620.
30. Ruokonen, E., Takala, J., Kari, A. and Alhava, E. (1991) Septic shock and multiple organ failure. Crit. Care Med. 19, 1146-1151.
31. Callegan, M.C., Engel, L.S., Hill, J.M. and O'Callaghan, R.J. (1994) Corneal virulence of Staphylococcus aureus: Roles of alpha-toxin and protein A in pathogenesis. Infect. Immun. 62, 2478-2482.
32. Moreillon, P., Entenza, J.M., Franciole, P., McDevitt, D., Foster, T.J., Francois, P. and Vaudaux, P. (1995) Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63, 4738-4743.
33. Konig, B., Prevost, G., Piemont, Y. and Konig, W. (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human monocytes. J. Infect. Dis. 171, 607-613.
34. Bernheimer, A. and Schwartz, L.L. (1963) Isolation and composition of Staphylococcal alpha toxin. J. Gen. Microbiol. 30, 455-468.
35. McNiven, A.C., Owen, P. and Arbuthnott, J.P. (1972) Multiple forms of Staphylococcal alpha-toxin. J. Med. Microbiol. 5, 113-122.
36. Bhakdi, S., Muhly, M., Mannhardt, U., Hugo, F., Klapettek, K., Muellereckhardt, C. and Roka, L. (1988) Staphylococcal a toxin promotes blood coagulation via attack on human platelets. J. Exp. Med. 168, 527-542.
37. Adlam, C., Ward, P.D., McCartney, A.C., Arbuthnott, J.P. and Thorley, C.M. (1977) Effect of immunization with highly purified alpha- and beta-toxins on Staphylococcal mastitis in rabbits. Infect. Immun. 17, 250-256.
38. Colacicco, G., Basu, M.K., Buckelew, A.R. and Bernheimer, A.W. (1977) Surface properties of membrane systems: Transport of Staphylococcal d-toxin from aqueous to membrane phase. Biochim. Biophys. Acta 465, 378-390.
39. Durkin, J.P. and Shier, W.T. (1981) Staphylococcal delta toxin stimulates endogenous phospholipase A2 activity and prostaglandin synthesis in fibroblasts. Biochim. Biophys. Acta 663, 467-479.
40. Noda, M. (1993) Pathogenic factors of methicillin-resistant Staphylococcus aureus. In: Advance in Clinical Microbiology in 1993 (Kato, N., Ed.), pp. 338-346. SAINE, Tokyo (in Japanese).
41. Debets, J.M.H., Kampmeijer, Van der Linden, M.P.M.H., Buurman, W.A. and Van der Linden, C.J. (1989) Plasma tumor necrosis factor and mortality in critically ill patients. Crit. Care Med. 17, 489-494.